APA
Amiri-Kordestani L., Blumenthal G. M., Xu Q. C., Zhang L., Tang S. W., Ha L., Weinberg W. C., Chi B., Candau-Chacon R., Hughes P., Russell A. M., Miksinski S. P., Chen X. H., McGuinn W. D., Palmby T., Schrieber S. J., Liu Q., Wang J., Song P., Mehrotra N., Skarupa L., Clouse K., Al-Hakim A., Sridhara R., Ibrahim A., Justice R., Pazdur R. & Cortazar P. (20150707). FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Chicago
Amiri-Kordestani Laleh, Blumenthal Gideon M, Xu Qiang Casey, Zhang Lijun, Tang Shenghui W, Ha Linan, Weinberg Wendy C, Chi Bo, Candau-Chacon Reyes, Hughes Patricia, Russell Anne M, Miksinski Sarah Pope, Chen Xiao Hong, McGuinn W David, Palmby Todd, Schrieber Sarah J, Liu Qi, Wang Jian, Song Pengfei, Mehrotra Nitin, Skarupa Lisa, Clouse Kathleen, Al-Hakim Ali, Sridhara Rajeshwari, Ibrahim Amna, Justice Robert, Pazdur Richard and Cortazar Patricia. 20150707. FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Harvard
Amiri-Kordestani L., Blumenthal G. M., Xu Q. C., Zhang L., Tang S. W., Ha L., Weinberg W. C., Chi B., Candau-Chacon R., Hughes P., Russell A. M., Miksinski S. P., Chen X. H., McGuinn W. D., Palmby T., Schrieber S. J., Liu Q., Wang J., Song P., Mehrotra N., Skarupa L., Clouse K., Al-Hakim A., Sridhara R., Ibrahim A., Justice R., Pazdur R. and Cortazar P. (20150707). FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.
MLA
Amiri-Kordestani Laleh, Blumenthal Gideon M, Xu Qiang Casey, Zhang Lijun, Tang Shenghui W, Ha Linan, Weinberg Wendy C, Chi Bo, Candau-Chacon Reyes, Hughes Patricia, Russell Anne M, Miksinski Sarah Pope, Chen Xiao Hong, McGuinn W David, Palmby Todd, Schrieber Sarah J, Liu Qi, Wang Jian, Song Pengfei, Mehrotra Nitin, Skarupa Lisa, Clouse Kathleen, Al-Hakim Ali, Sridhara Rajeshwari, Ibrahim Amna, Justice Robert, Pazdur Richard and Cortazar Patricia. FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20150707.